1 active not recruiting, 1 recruiting, 1 withdrawn. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Active not recruiting 1, Recruiting 1, Withdrawn 1 |
Follow Cutaneous Squamous Cell Carcinoma: new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma trials Research Report on Cutaneous Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and Neck Cemiplimab, Radiation Therapy - Cutaneous Squamous Cell Carcinoma | Early Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 25 | 2026-09-01 | 2026-10-13 |
| Exercise to Boost Response to Checkpoint Blockade Immunotherapy Exercise, Checkpoint Blockade, Immune - Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma | Early Phase 1 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 22 | 2022-06-21 | 2026-09-15 |
| Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study Pramlintide - Cutaneous Squamous Cell Carcinoma | Early Phase 1 | Withdrawn | H. Lee Moffitt Cancer Center and Research Institute | 2020-01-30 | 2023-06-28 |
Skin Neoplasms (2) · Carcinoma, Merkel Cell (1) · Carcinoma, Squamous Cell (1) · Melanoma (1) · Motor Activity (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Behavior (1) · Carcinoma, Neuroendocrine (1) · DNA Virus Infections (1) · Infections (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Squamous Cell (1)
cemiplimab (2) · Exercise (1) · Immune Checkpoint Inhibitors (1) · Ipilimumab (1) · Nivolumab (1) · Radiotherapy (1) · avelumab (1) · pembrolizumab (1) · pramlintide (1)
H. Lee Moffitt Cancer Center and Research Institute (2) · Vanderbilt-Ingram Cancer Center (1)
United States (3)